Tag: Epilepsy

Dose-normalized concentrations of lamotrigine, levetiracetam, lacosamide, oxcarbazepine, and zonisamide decreased during pregnancy

Further study needed to determine long-term efficacy and safety and optimize patient selection

Establishing a genetic diagnosis for patients with unexplained infantile or childhood-onset epilepsy can help individualize treatment

Delays tied to more seizures prior to diagnosis, conversion to motor-type seizures, potentially preventable injuries

86 percent reduction seen in seizure frequency for children with intractable epilepsy, with no significant adverse events

After adjustment for prevalent and interim stroke, risk for developing epilepsy increased almost twofold

Initiating oxcarbazepine, but not levetiracetam, linked to increased incidence rate ratio for nontrauma fracture

Current evidence does not support increased suicidality for certain newer antiseizure medications; class warning may not be merited

No significant differences in language development seen at age 2 years for children born to mothers with epilepsy

No difference found in primary outcome of Verbal Index score at age 3 years with fetal exposure to ASM or for those born to healthy women